PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • November 3rd, 2009 • Stem Cell Therapy International, Inc. • Services-medical laboratories • New York
Contract Type FiledNovember 3rd, 2009 Company Industry JurisdictionThis Preferred Stock Purchase Agreement (“Agreement”) is entered into and effective as of November 2, 2009 (“Effective Date”), by and among Stem Cell Therapy International, Inc., a Nevada corporation (“Company”), and Socius Capital Group, LLC, a Delaware limited liability company, dba Socius Life Sciences Capital Group, LLC (including its designees, successors and assigns, “Investor”).